Pharmacokinetics of phenylethylacetylurea (pheneturide), an old antiepileptic drug
- 1 October 1979
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 7 (5) , 453-462
- https://doi.org/10.1007/bf01062387
Abstract
The pharmacokinetics of pheneturide (a decarboxylation product of phenobarbital), used to prevent psychomotor seizures for many years, was studied in normal human volunteers. To measure the drug in plasma and urine, a highly sensitive and reproducible thin-layer chromatography-reflectance spectrophotometric assay was developed. The results show that pheneturide follows first-order kinetics in the dose range studied. Its half-life after single doses is 54 hr (range 31–90), and its total body clearance (100% nonrenal) is 2.6 liters/hr (range 1.73–3.59). After repetitive administration, half-life is 40 hr (but clearance remains unchanged because of a lower volume of distribution). Because of the long half-life, repetitive administration results in a continuous steady-state level and makes this drug (kinetically) ideal for long-term use.This publication has 7 references indexed in Scilit:
- Standardization of the direct spectrophotometric quantitative analysis of chromatograms : IV. A comparatives study on the most common mathematical treatments of thin-layer densitometric problemsJournal of Chromatography A, 1974
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- [Experiences with Pheneturid in refractory epilepsy].1972
- TREATMENT OF INTRACTABLE TEMPORAL LOBE EPILEPSY WITH PHENETURIDEActa Neurologica Scandinavica, 1967
- Trinuride in the Treatment of Major EpilepsyEpilepsia, 1965
- [Contribution to the therapy of epilepsy with acetylureas].1960
- Anticonvulsant and Toxic Effects of Alpha‐Phenyl=Butyryl UreaNeurology, 1951